The high-tech sector has effectively utilized patent pools and standardization to manage commercial risks, facilitate collaboration, and promote IP commercialization. Patent pools and standard essential patents, e.g., 5G, 6G, and cellular communication protocol, have been deployed as a valuable tool for streamlining the licensing process and reducing litigation risks in the high-tech space. We are at a pivotal moment where the convergence of life sciences and technology is transforming the industry. This session aims to discuss licensing issues regarding life sciences platform technologies, including CRISPR and mRNA pools, and lessons and insights from the high-tech sector.
